In the central nervous system, cPLA2 activation has been implicated in the pathogenesis of a number of neurodegenerative (Alzheimer’s disease, Parkinson’s disease and prion diseases) and neuropsychiatric (schizophrenia and depressive disorder) diseases3–7. This evidence concerns the gene PLA2G4A and Alzheimer disease.